Published in Am J Transplant on December 01, 2005
Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol (2009) 5.02
Long-term cancer risk of immunosuppressive regimens after kidney transplantation. J Am Soc Nephrol (2010) 1.45
Malignancy after renal transplantation: the role of immunosuppression. Nat Rev Nephrol (2010) 0.98
Management and prevention of post-transplant malignancies in kidney transplant recipients. Clin Kidney J (2015) 0.97
Liver transplantation: immunosuppression and oncology. Curr Opin Organ Transplant (2014) 0.94
Incidence of malignancy after living kidney transplantation: a multicenter study from iran. J Cancer (2012) 0.89
Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies. Curr Hematol Malig Rep (2013) 0.89
Posttransplant lymphoproliferative disease after pediatric solid organ transplantation. Clin Dev Immunol (2013) 0.83
Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation. World J Hepatol (2015) 0.82
Toxicities of immunosuppressive treatment of autoimmune neurologic diseases. Curr Neuropharmacol (2011) 0.82
The necrotic signal induced by mycophenolic acid overcomes apoptosis-resistance in tumor cells. PLoS One (2009) 0.81
Is newer safer? Adverse events associated with first-line therapies for ANCA-associated vasculitis and lupus nephritis. Clin J Am Soc Nephrol (2014) 0.81
Cancer and scleroderma: a paraneoplastic disease with implications for malignancy screening. Curr Opin Rheumatol (2015) 0.81
Review on immunosuppression in liver transplantation. World J Hepatol (2015) 0.79
Incidence, risk factors and outcomes of de novo malignancies post liver transplantation. World J Hepatol (2016) 0.78
Risk factors and outcomes for the development of malignancy in lung and heart-lung transplant recipients. Can Respir J (2010) 0.78
Malignancies after pediatric kidney transplantation: more than PTLD? Pediatr Nephrol (2013) 0.78
The development of squamous cell carcinoma in a patient after kidney transplantation: a case report. Postepy Dermatol Alergol (2013) 0.78
Renal cell carcinoma with proliferative lupus nephritis. BMJ Case Rep (2015) 0.77
Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage. Oncotarget (2015) 0.76
Cancer and autoimmunity: Harnessing longitudinal cohorts to probe the link. Best Pract Res Clin Rheumatol (2016) 0.76
Immunosuppression and Multiple Primary Malignancies in Kidney-Transplanted Patients: A Single-Institute Study. Biomed Res Int (2015) 0.75
Late onset epstein barr virus seropositive posttransplant lymphoproliferative disorder in two renal transplant receivers. Turk J Haematol (2013) 0.75
Differential Sensitivities of Fast- and Slow-cycling Cancer Cells to Inosine Monophosphate Dehydrogenase 2 Inhibition by Mycophenolic Acid. Mol Med (2015) 0.75
A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders. Clin J Am Soc Nephrol (2017) 0.75
Efficacy of mycophenolate treatment in adults with steroid-dependent/frequently relapsing idiopathic nephrotic syndrome. Clin Kidney J (2017) 0.75
Using a weaning immunosuppression protocol in liver transplantation recipients with hepatocellular carcinoma: a compromise between the risk of recurrence and the risk of rejection? Transl Gastroenterol Hepatol (2017) 0.75
High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med (1995) 5.41
Autologous stimulation of human lymphocyte subpopulation. J Exp Med (1975) 4.80
Effect of blood transfusions on subsequent kidney transplants. Transplant Proc (1973) 3.42
Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial. Ann Oncol (2004) 2.97
The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators. N Engl J Med (1998) 2.90
Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med (1978) 2.52
Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation. Lancet (1995) 2.50
Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med (1998) 2.48
Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases. Ann Oncol (2003) 2.16
The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. Transplantation (1995) 2.13
Influence of test technique on sensitization status of patients on the kidney transplant waiting list. Am J Transplant (2013) 2.12
Equitable allocation of HLA-compatible kidneys for local pools and minorities. N Engl J Med (1994) 2.12
Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry. N Engl J Med (1992) 2.09
[Immunological aspects of kidney transplantation in Switzerland 1981-1992. Swiss Transplant Work Group Kidney Transplantation]. Schweiz Med Wochenschr (1995) 1.91
Transformations of maps to investigate clusters of disease. Soc Sci Med (1988) 1.89
Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation (1998) 1.78
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant (2010) 1.65
Successful renal allografts across a positive cross-match for donor B-lymphocyte alloantigens. Lancet (1976) 1.63
The hyperfiltration hypothesis in human renal transplantation. Transplantation (1994) 1.63
Living unrelated donor kidney transplantation. Kidney Int (2000) 1.61
Evaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpes. Antimicrob Agents Chemother (2003) 1.59
Influence of race on kidney transplant survival. Transplant Proc (1977) 1.58
Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion (2000) 1.58
Structure of murine Ia antigens: partial NH2-terminal amino acid sequences of products of the I-E or I-C subregion. Proc Natl Acad Sci U S A (1977) 1.56
HLA matching and cadaver kidney transplant survival in North America: influence of center variation and presensitization. Transplantation (1977) 1.56
Impaired in-vitro lymphocyte responses in patients with elevated pentachlorophenol (PCP) blood levels. Arch Environ Health (1995) 1.52
Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg (1980) 1.45
Suppression of lymphocyte transformation by aspirin. Lancet (1973) 1.43
Evaluation of HLA matching for CREG antigens in Europe. Transplantation (1999) 1.43
Paired kidney exchange is not a solution to ABO incompatibility. Transplantation (1998) 1.43
Reassessing the impact of donor HLA-C genotype on long-term liver transplant survival. Am J Transplant (2009) 1.43
HLA DNA typing and transplantation. Immunity (2001) 1.42
Inhibition of pyruvate dehydrogenase complex (PDHC) by antipsychotic drugs. Biol Psychiatry (1991) 1.41
Poor kidney-transplant survival in recipients with frozen-blood transfusions or no transfusions. Lancet (1974) 1.40
IL-6 independent monocyte/B cell defect in renal transplant recipients with long-term stable graft function. Transplantation (1994) 1.39
Lymphocyte abnormalities in ankylosing spondylitis. Ann Rheum Dis (1977) 1.39
Sjögren's syndrome association with HLA-Dw3. N Engl J Med (1977) 1.32
Defective T cell function in atopic dermatitis. J Allergy Clin Immunol (1976) 1.26
A clinicopathological study of sinonasal neuroendocrine carcinoma and sinonasal undifferentiated carcinoma. Laryngoscope (2000) 1.24
Mental disorders and drug abuse in persons living with HIV/AIDS. AIDS Care (2004) 1.22
Improved kidney graft survival in nontransfused recipients. Transplant Proc (1987) 1.22
HLA class I DNA typing of 215 "HLA-A, -B, -DR zero mismatched" kidney transplants. Tissue Antigens (1997) 1.19
Characterization of functionally distinct lymphoid and myeloid cells from human blood and bone marrow. I. Separation by a buoyant density gradient technique. J Immunol Methods (1977) 1.19
Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation. N Engl J Med (2000) 1.18
The effect of race and ethnicity on kidney allograft outcome. Clin Transpl (1995) 1.18
Induction of high kidney graft survival rate by multiple transfusion. Lancet (1981) 1.18
Modified therapeutic community for homeless mentally ill chemical abusers: treatment outcomes. Am J Drug Alcohol Abuse (2000) 1.17
Identification of unresponsive kidney-transplant recipients. Lancet (1972) 1.16
Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment. Int J Clin Pract (2009) 1.15
New developments in the epidemiology, natural history and management of genital herpes. Antiviral Res (1999) 1.14
Multiple sclerosis and high incidence of a B lymphocyte antigen. Science (1976) 1.14
Pathological and clinical characterization of the 'troubled transplant': data from the DeKAF study. Am J Transplant (2010) 1.14
Effect of splenectomy on human renal transplants. Transplantation (1973) 1.12
QuickMap: a public tool for large-scale gene therapy vector insertion site mapping and analysis. Gene Ther (2009) 1.11
Chemical characterization of products of the H-2 complex. Cold Spring Harb Symp Quant Biol (1977) 1.11
Calculations on long-term graft and patient survival in human kidney transplantation. Transplant Proc (1977) 1.10
Histopathologic clusters differentiate subgroups within the nonspecific diagnoses of CAN or CR: preliminary data from the DeKAF study. Am J Transplant (2009) 1.10
Peptide map analyses of murine Ia antigens of the I-E subregion using HPLC. Nature (1979) 1.10
Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection. Transplantation (2000) 1.09
Specific enzymatic treatment of bovine and human articular cartilage: implications for integrative cartilage repair. Arthritis Rheum (2002) 1.09
Dominant effect of transfusions on kidney graft survival. Transplantation (1980) 1.07
Outcome of kidney transplants and suppression of mixed leukocyte culture by plasma. Transplant Proc (1973) 1.07
Autoimmune panleukopenia. N Engl J Med (1976) 1.07
Association of HLA antigen a9 with progressive systemic sclerosis (scleroderma). Tissue Antigens (1978) 1.07
Repeatability and validity of a field kit for estimation of cholinesterase in whole blood. Occup Environ Med (1995) 1.07
Prediction of long-term kidney transplant survival rates by monitoring early graft function and clinical grades. Transplantation (1978) 1.06
Associations of blood levels of PCB, HCHS, and HCB with numbers of lymphocyte subpopulations, in vitro lymphocyte response, plasma cytokine levels, and immunoglobulin autoantibodies. Environ Health Perspect (2001) 1.06
Detection of viral DNA to evaluate outcome of antiviral treatment of patients with recurrent genital herpes. J Clin Microbiol (1996) 1.06
Evaluation of Belzer and Collins kidney-preservation methods. Lancet (1973) 1.06
Monoclonal anti-A from a hybrid-myeloma: evaluating as a blood grouping reagent. Vox Sang (1980) 1.06
Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer. Eur J Cancer (2004) 1.04
The UNOS Scientific Renal Transplant Registry. Clin Transpl (1999) 1.04
The antigen-binding domain of a human IgG-anti-F(ab')2 autoantibody. Proc Natl Acad Sci U S A (1997) 1.04
Cutaneous sensitivity and in vitro responsiveness of lymphocytes in patients with disseminated coccidioidomycosis. J Infect Dis (1975) 1.04
Second kidney transplants and presensitization. Transplant Proc (1972) 1.03
Correlation of HLA matching with kidney graft survival in patients with or without cyclosporine treatment. Transplantation (1985) 1.03
HL-A and kidney transplants: reexamination. Transplantation (1974) 1.03
Comparison of kidney transplant survival among transplant centers. Transplantation (1975) 1.03
Enhancement of kidney graft survival by blood transfusions. Transplant Proc (1977) 1.03
Reduced incidence of rectal cancer, compared to gastric and colonic cancer, in a population of 73,076 men and women chronically immunosuppressed. Clin Cancer Res (1997) 1.02
The T-cell suppressive effect of bufadienolides: structural requirements for their immunoregulatory activity. Int Immunopharmacol (2001) 1.02
Mechanical stretch induces vascular permeability factor in human mesangial cells: mechanisms of signal transduction. Proc Natl Acad Sci U S A (1997) 1.01
Kidney paired donation in the presence of donor-specific antibodies. Kidney Int (2013) 1.01
Observation of quantum shock waves created with ultra- compressed slow light pulses in a Bose-Einstein condensate. Science (2001) 1.01
Effect of blood-group on relation between HLA match and outcome of cadaver kidney transplants. Lancet (1977) 1.01
Effects of changes in the criteria for nationally shared kidney transplants for HLA-matched patients. Transplantation (1998) 1.01
Partial N-terminal amino acid sequence analyses and comparative tryptic peptide maps of murine Ia molecules encoded by the I-A subregion. Eur J Immunol (1979) 1.00
Lymphocyte autoantibodies and alloantibodies in HIV-positive haemophilia patients. Clin Exp Immunol (1989) 0.99
Commentary: does immune suppression increase risk of developing acute myeloid leukemia? Leukemia (2011) 0.98
Absence of immunization effect in human-kidney retransplantation. N Engl J Med (1978) 0.98
Risk rate and long-term kidney transplant survival. Clin Transpl (1996) 0.98
A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection. Transplantation (2001) 0.97
Influence of sex on histocompatibility matching in renal transplantation. Lancet (1977) 0.97
Should pediatric patients wait for HLA-DR-matched renal transplants? Am J Transplant (2008) 0.97
Thymus-dependent lymphocytes in human bone marrow. J Clin Invest (1975) 0.96
Determinants of long-term survival of pediatric kidney grafts reported to the United Network for Organ Sharing kidney transplant registry. Pediatr Transplant (2001) 0.96
Prolongation effect of blood transfusions on kidney graft survival. Transplantation (1976) 0.95
Effect of delayed graft function on short- and long-term kidney graft survival. Clin Transpl (1997) 0.95
The orthopedic aspects of Gaucher disease. Clin Orthop Relat Res (1979) 0.95
Studies on the strength of HLA antigens in related donor kidney transplants. Transplantation (1977) 0.95